Co-delivery of thioredoxin 1 shRNA and doxorubicin by folate-targeted gemini surfactant-based cationic liposomes to sensitize hepatocellular carcinoma cells

Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma

(2015) Changping Li et al.   Oncotarget

Folate Receptor-Targeting Gold Nanoclusters as Fluorescence Enzyme Mimetic Nanoprobes for Tumor Molecular Colocalization Diagnosis

(2014) Dehong Hu et al.   Theranostics

Gene and doxorubicin co-delivery system for targeting therapy of glioma

(2012) Shuhuan Liu et al.   BIOMATERIALS

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles

(2011) Ling Xiao et al.   BIOMATERIALS

Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles

(2010) Peng Yang et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Chitosan as a condensing agent induces high gene transfection efficiency and low cytotoxicity of liposome

(2010) Ruizhen Liu et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Redox Regulation of Cell Survival by the Thioredoxin Superfamily: An Implication of Redox Gene Therapy in the Heart

(2009) Md. Kaimul Ahsan et al.   ANTIOXIDANTS & REDOX SIGNALING

Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect

(2009) Nikken Wiradharma et al.   BIOMATERIALS

Novel treatments for hepatocellular cancer

(2009) S.H. Kerr et al.   CANCER LETTERS

Gemini Surfactants: A New Family of Building Blocks for Non-Viral Gene Delivery Systems

(2008) Shawn Wettig et al.   CURRENT GENE THERAPY